Director Assistant at Changhai Hospital, Naval Medical University, China
Assoc. Prof. Dr. Cheng Xin is an Associate Chief Physician and Director Assistant in Colorectal Surgery at Changhai Hospital, Naval Medical University π₯. He is a member of the Oncology and Gastroenterology Professional Committee of the Chinese Anti-Cancer Association ποΈ and the Surgery and Digestive Endoscopy Branch of the Shanghai Branch of the Chinese Medical Association π¬. He serves as an Editorial Board Member for the Journal of Immunoassay and Clinical Studies π and is an Oncology Channel Editor for Medical Reference Daily π°. Additionally, he is a Shanghai Medical Volunteer Alliance Aerial Medical Expert π, contributing to medical outreach.
Publication Profile
Orcid
π Academic and Professional Background
Assoc. Prof. Dr. Cheng Xin is an Associate Chief Physician and Director Assistant in Colorectal Surgery at Changhai Hospital, Naval Medical University π₯. With expertise in colorectal surgery, oncology, and gastroenterology π©Ί, he has established a strong research foundation in surgical and medical sciences π¬. His contributions extend to advancing minimally invasive techniques, improving cancer treatment protocols, and enhancing digestive disease management ποΈ. As a dedicated medical professional, he actively participates in clinical practice, academic research, and medical education, shaping the future of gastrointestinal surgery while ensuring the highest standards of patient care. β
π¬ Research Focus
Assoc. Prof. Dr. Cheng Xin specializes in colorectal cancer research, focusing on tumor immunology, surgical oncology, and minimally invasive techniques π₯. His studies explore neutrophil heterogeneity, genetic markers for recurrence prediction, and postoperative complications in colorectal cancer ποΈ. He has also contributed to understanding peritoneal metastases, drug resistance mechanisms, and the role of microRNAs in cancer progression π§¬. Additionally, his work extends to laparoscopic surgery and its impact on gastrointestinal diseases. His research integrates clinical data analysis, molecular biology, and surgical innovation, making significant strides in oncology and digestive health. β
Publication Top Notes
-
“The optimal surgical time after stent placement in obstructive colorectal cancer: impact on long-term survival of patients” (2024) β This article examines how the timing of surgery after stent placement affects long-term survival in patients with obstructive colorectal cancer.
-
“A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer” (2023) β This study identifies a 9-gene signature that can predict postoperative recurrence in stage II/III colorectal cancer patients.
-
“Pelvic floor peritoneum reconstruction is a protective factor for defecation dysfunction after laparoscopic anterior resection in patients with middle and low rectal cancer” (2022) β This research suggests that reconstructing the pelvic floor peritoneum can protect against defecation dysfunction following laparoscopic anterior resection in rectal cancer patients.
-
“PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab” (2021) β This article explores the overexpression of PUM1 in colon cancer cells that have developed resistance to the drug Cetuximab.
-
“miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells” (2020) β This study investigates how miR-365a-3p influences the ADAM10-JAK-STAT signaling pathway to inhibit growth and metastasis in colorectal cancer cells.
-
“The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery” (2020) β This research assesses how the number of tumor deposits impacts prognosis in colorectal cancer patients post-surgery.
-
“Feasibility and safety of single-incision laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy in an ambulatory setting” (2019) β This article compares the feasibility and safety of single-incision versus conventional laparoscopic cholecystectomy in outpatient settings.
π
Conclusion
Assoc. Prof. Dr. Cheng Xinβs extensive research involvement, leadership in surgical oncology and gastroenterology, editorial contributions, and role in medical education make him a strong candidate for the Best Researcher Award. His work significantly impacts both the academic and clinical fields, aligning well with the awardβs criteria. β